Skip to content
10-Q

Quarterly Report

Diplomat Pharmacy, Inc.

0001558370-19-010799

← back to feed
Filed
Nov 12, 2019 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2019 · Nov 8, 2019 75.97M sh
Shares Diluted Q3 2019 · Sep 30, 2019 75.51M sh
Shares Diluted Q3 2019 · Sep 30, 2019 74.9M sh
Shares Diluted Q3 2019 · Sep 30, 2018 74.74M sh
Shares Diluted Q3 2019 · Sep 30, 2018 74.18M sh
Capex Q3 2019 · Sep 30, 2019 $3.96M
Capex Q3 2019 · Sep 30, 2018 $7.88M
Operating Cash Flow Q3 2019 · Sep 30, 2019 $108.05M
Operating Cash Flow Q3 2019 · Sep 30, 2018 $33.21M
Cash And Equivalents Q3 2019 · Sep 30, 2019 $8.42M
Cash And Equivalents Q3 2019 · Dec 31, 2018 $9.49M
Cash And Equivalents Q3 2019 · Sep 30, 2018 $8.21M
Cash And Equivalents Q3 2019 · Dec 31, 2017 $84.25M
Stockholders Equity Q3 2019 · Sep 30, 2019 $131.03M
Stockholders Equity Q3 2019 · Jun 30, 2019 $299.46M
Stockholders Equity Q3 2019 · Mar 31, 2019 $457.88M
Stockholders Equity Q3 2019 · Dec 31, 2018 $465.08M
Stockholders Equity Q3 2019 · Sep 30, 2018 $764.86M
Stockholders Equity Q3 2019 · Jun 30, 2018 $757.47M
Stockholders Equity Q3 2019 · Mar 31, 2018 $754M
Stockholders Equity Q3 2019 · Dec 31, 2017 $749.5M
Current Liabilities Q3 2019 · Sep 30, 2019 $991.54M
Current Liabilities Q3 2019 · Dec 31, 2018 $558.59M
Total Liabilities Q3 2019 · Sep 30, 2019 $1.03B
Total Liabilities Q3 2019 · Dec 31, 2018 $1.01B
Current Assets Q3 2019 · Sep 30, 2019 $542.18M
Current Assets Q3 2019 · Dec 31, 2018 $556.26M
Total Assets Q3 2019 · Sep 30, 2019 $1.16B
Total Assets Q3 2019 · Dec 31, 2018 $1.48B
Sga Expense Q3 2019 · Sep 30, 2019 $74.99M
Sga Expense Q3 2019 · Sep 30, 2019 $238.68M
Sga Expense Q3 2019 · Sep 30, 2018 $83.42M
Sga Expense Q3 2019 · Sep 30, 2018 $255.71M
Net Income Q3 2019 · Sep 30, 2019 −$177.28M
Net Income Q3 2019 · Sep 30, 2019 −$351.04M
Net Income Q3 2019 · Sep 30, 2018 $169K
Net Income Q3 2019 · Sep 30, 2018 −$4.24M
Operating Income Q3 2019 · Sep 30, 2019 −$167.86M
Operating Income Q3 2019 · Sep 30, 2019 −$320.46M
Operating Income Q3 2019 · Sep 30, 2018 $9.94M
Operating Income Q3 2019 · Sep 30, 2018 $26.45M
Gross Profit Q3 2019 · Sep 30, 2019 $63.39M
Gross Profit Q3 2019 · Sep 30, 2019 $215.33M
Gross Profit Q3 2019 · Sep 30, 2018 $93.36M
Gross Profit Q3 2019 · Sep 30, 2018 $282.15M
Cost Of Revenue Q3 2019 · Sep 30, 2019 $1.24B
Cost Of Revenue Q3 2019 · Sep 30, 2019 $3.63B
Cost Of Revenue Q3 2019 · Sep 30, 2018 $1.28B
Cost Of Revenue Q3 2019 · Sep 30, 2018 $3.85B
Revenue Q3 2019 · Sep 30, 2019 $1.3B
Revenue Q3 2019 · Sep 30, 2019 $3.85B
Revenue Q3 2019 · Sep 30, 2018 $1.37B
Revenue Q3 2019 · Sep 30, 2018 $4.13B
Long Term Debt Q3 2019 · Dec 31, 2018 $438.37M